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Spatial Genome Organization and Its
Emerging Role as a Potential
Diagnosis Tool
Karen J. Meaburn*
Cell Biology of Genomes Group, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
In eukaryotic cells the genome is highly spatially organized. Functional relevance of
higher order genome organization is implied by the fact that specific genes, and even
whole chromosomes, alter spatial position in concert with functional changes within
the nucleus, for example with modifications to chromatin or transcription. The exact
molecular pathways that regulate spatial genome organization and the full implication to
the cell of such an organization remain to be determined. However, there is a growing
realization that the spatial organization of the genome can be used as a marker of
disease. While global genome organization patterns remain largely conserved in disease,
some genes and chromosomes occupy distinct nuclear positions in diseased cells
compared to their normal counterparts, with the patterns of reorganization differing
between diseases. Importantly, mapping the spatial positioning patterns of specific
genomic loci can distinguish cancerous tissue from benign with high accuracy. Genome
positioning is an attractive novel biomarker since additional quantitative biomarkers
are urgently required in many cancer types. Current diagnostic techniques are often
subjective and generally lack the ability to identify aggressive cancer from indolent,
which can lead to over- or under-treatment of patients. Proof-of-principle for the use
of genome positioning as a diagnostic tool has been provided based on small scale
retrospective studies. Future large-scale studies are required to assess the feasibility of
bringing spatial genome organization-based diagnostics to the clinical setting and to
determine if the positioning patterns of specific loci can be useful biomarkers for cancer
prognosis. Since spatial reorganization of the genome has been identified in multiple
human diseases, it is likely that spatial genome positioning patterns as a diagnostic
biomarker may be applied to many diseases.
Keywords: genome organization, nuclear architecture, spatial positioning, gene positioning, disease, cancer,
diagnosis
Abbreviations: FISH, fluorescence in situ hybridization; HGPS, Hutchinson-Gilford progeria syndrome; ICF,
immunodeficiency, centromere instability and facial anomalies syndrome; NE, nuclear envelope; NPC, nuclear pore
complex; PSA, prostate-specific antigen; TAD, topologically associating domain.
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A SHORTAGE OF QUANTITATIVE
CANCER BIOMARKERS
Cancer is a major public health issue. In 2012 alone, across the
globe approximately 14.1 million people were diagnosed with
cancer and 8.2 million people lost their lives to it (Torre et al.,
2015). In developed countries a third to a half of the population
will be diagnosed with cancer during their lifetime (Ahmad et al.,
2015; Siegel et al., 2016). Not only is cancer a leading cause of
morbidity, it is also a leading cause of mortality. In fact, only heart
disease accounts for more deaths than cancer; although cancer
is the most frequent cause of death for 40–79 year olds (Siegel
et al., 2016). Cancer is a heterogeneous collection of diseases. The
most prevalent cancers are lung, breast, prostate and colorectal
carcinomas, which, when combined account for∼43% of all new
cancer diagnoses (Torre et al., 2015; Siegel et al., 2016). These
four cancers are also leading causes of cancer-related mortality,
contributing ∼40% of the total (Torre et al., 2015; Siegel et al.,
2016). Even cancers derived from the same organ can be quite
heterogeneous from each other, and are further stratified based
on morphological patterns, clinical features and/or molecular
characteristics. This sub-grouping is important clinically because
the appropriate treatment and the risk of recurrence or lethality
differ between subgroups. For example, HER2 (also known as
ERBB2) positive breast cancers have a poorer prognostic outlook
than luminal breast cancers (Sorlie et al., 2001; Ferte et al.,
2010), and many HER2-positive breast cancers respond well to
trastuzumab (Herceptin) treatment, while endocrine therapy is
an effective treatment option for the majority of luminal breast
cancers (Ferte et al., 2010; Schnitt, 2010).
A key to the successful treatment of any disease is accurate
diagnosis, preferably at an early stage in disease progression
when treatments are generally more effective and less aggressive.
However, early detection of cancer, particularly by population-
based cancer screenings such as mammography or serum PSA
levels, often comes at the cost of overdiagnosis (Welch and
Black, 2010; Bleyer and Welch, 2012; Sandhu and Andriole,
2012). Overdiagnosis is the detection of indolent cancers that
will remain asymptomatic during the patient’s lifetime and,
as such, do not require treatment. Most commonly, cancer
diagnosis is made following histological examination of biopsy
or surgical tissue specimens. Unfortunately, in most instances
there is a limit to the prognostic information that can be
gleaned from histological analysis, and the pathologist is unable
distinguish indolent from aggressive cancers with a high degree
of certainty. Presently, due to a lack of additional markers
to identify aggressive cancer, many overdiagnosed patients are
being overtreated since they are receiving unnecessary therapies.
Not only are these patients receiving no therapeutic benefit, as
their cancer would never have significantly progressed, they are
actually being harmed by the cancer treatment itself, because
treatments can have both short-term and long-term effects that
cause illness, reduce quality of life, create large financial burdens
(for example by loss of income), and can even lead to death
(Cooperberg et al., 2010; Welch and Black, 2010; Bleyer and
Welch, 2012; Sandhu and Andriole, 2012). It has become a major
focus of research to find markers that can distinguish between
indolent and aggressive cancers, to aid the determination of the
best possible treatment plan for the patient.
TARGETING THE NUCLEUS IN THE
SEARCH FOR CLINICALLY RELEVANT
BIOMARKERS
Molecular markers, by their very nature, tend to be highly
quantifiable, and are a good potential source of diagnostic and
prognostic cancer biomarkers (Ferte et al., 2010). However, few
molecular markers are currently in routine clinical practice (Ferte
et al., 2010). An exciting area for exploration to identify novel
biomarkers is cancer-related changes in the architecture of the
cell nucleus (Veltri and Christudass, 2014). This is not without
precedence and changes in nuclear structure, such as nuclear
size, shape, prominence of nucleoli and chromatin texture, have
long been used by pathologists as part of their criteria to identify
cancerous cells (Zink et al., 2004b; Veltri and Christudass, 2014).
Moreover, identifying chromosomal translocations is important
for diagnosing hematological cancers, as specific translocations
characterize the type of leukemia or lymphoma, are associated
with distinct clinical features and are often indicative of the
appropriate treatment (Mitelman et al., 2007). For example,
chronic myeloid leukemia is diagnosed after the cytogenetic
detection of t(9;22)(q34;q11), the Philadelphia chromosome,
which results in a BCR-ABL fusion protein. Tyrosine kinase
inhibitors (Imatinib/Gleevec) inhibit the activity of the resultant
oncogenic fusion protein and use of this targeted therapy
results in exceptionally high rates of remission for chronic
myeloid leukemia patients (Hehlmann et al., 2007). FISH, a
technique used to visualize selected sequences of DNA within
interphase nuclei (Figures 1A,B) or on mitotic chromosomes,
is one method used in clinical practice to detect the presence
of specific translocations (Muhlmann, 2002; Zink et al., 2004b;
Hehlmann et al., 2007). FISH is also used clinically to detect other
chromosomal aberrations in solid and hematological cancers,
such as amplifications of the ERBB2 locus in breast cancer, to aid
diagnosis or as a prognostic marker (Muhlmann, 2002; Lambros
et al., 2007; Hastings, 2010). Changes in gene expression profiles
can also be useful diagnostically. For instance, there are several
commercially available assays with prognostic value for various
sub-types of breast cancer based on the gene expression profiles
of between 2 and 97 genes (Dai et al., 2015).
Beyond gene expression changes and genomic aberrations,
there are multiple other aspects of nuclear structure and function
that are deregulated in cancer and could be exploited clinically.
For example, alteration in nuclear shape, size, chromatin texture,
global levels and patterns of heterochromatin and/or histone
modifications during carcinogenesis have been shown to be
predictive of cancer progression (Zink et al., 2004b; Nielsen
et al., 2008; Veltri and Christudass, 2014; Hveem et al., 2016).
Aberrant expression of A- and/or B- type lamins is a common
feature of many types of cancer, including lung, breast, prostate,
colorectal, skin, and gut carcinomas (Broers et al., 1993; Moss
et al., 1999; Venables et al., 2001; Willis et al., 2008; Belt et al.,
2011; Kong et al., 2012; Wazir et al., 2013; Broers and Ramaekers,
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FIGURE 1 | Non-random organization of the genome. (A,B) Whole chromosomes and genes can be visualized within interphase nuclei using FISH.
(A) Chromosome 11 (green) in an interphase nucleus (blue) of the breast epithelial cell line MCF10A. (B) SPDEF (red) gene loci in normal prostate tissue
(formalin-fixed paraffin embedded tissue) nuclei (blue). The spatial organization of the genome is characterized in several ways: (C) Radial positioning describes the
position of a locus relative to the center and periphery of the nucleus. Gene-poor chromosomes (yellow) generally locate to the nuclear periphery, whilst gene-rich
chromosomes have a preference for the nuclear interior. (D–G) Relative positioning describes the position of a locus relative to another nuclear landmark. Association
frequencies can either be measured on a per cell basis (i.e., the number of nuclei in a population with at least one copy of a gene or chromosome in close proximity
to the given landmark) or on a per allele basis. Examples of types of relative positioning include: (D) The position of a locus relative to another locus. The yellow and
orange chromosomes are in close spatial proximity, whereas the orange and red chromosomes are distal. (E) Association with the nuclear envelope (NE). Some
genes preferentially co-localize with the NE (yellow gene). (F) Association with a nuclear body such as a splicing speckle. (G) The position of gene relative its own
chromosome territory. Some gene rich loci loop out of the bulk of the chromosome territory when highly expressed.
2014; Saarinen et al., 2015). The majority of lamin proteins form
the nuclear lamina, which underlies the NE, and an additional
pool of intranuclear lamins exists (Dittmer and Misteli, 2011).
Although highly variable between individual cancers and cancer
sub-types, a broad generalization suggests cancers with lower
expression levels of A-type lamins tend to have poorer outcomes
and more aggressive phenotypes (Belt et al., 2011; Wazir et al.,
2013; Saarinen et al., 2015). This is in line with findings that cells
with a deficiency in A-type lamins can migrate more easily though
narrow constrictions (Davidson et al., 2014), which may aid
metastatic progression, and that reduced lamin A has been linked
to a higher cellular proliferation rate (Venables et al., 2001).
However, the associations between reduced lamin expression and
prognosis tend to be weak or based on a low number of patients,
and there are conflicting studies that find higher levels of A-type
lamin expression to be predictive of a poor outcome (Willis et al.,
2008; Kong et al., 2012). Since difference in lamin expression can
vary between sub-groups of cancers, for example between small
cell lung cancer and non-small cell lung cancer (Broers et al.,
1993), future studies with more defined cohorts of patients may
prove enlightening. It is not only changes in expression, mis-
localization of lamins to the cytoplasm (Broers et al., 1993; Moss
et al., 1999), or the nucleolus (Venables et al., 2001) have also been
observed in some cancer specimens. The reduction and/or loss
of lamin isoforms may be an early event in carcinogenesis as, at
least in cervical cancer, it can occur before neoplasia is detectable
(Capo-Chichi et al., 2016). Other nuclear bodies, including the
nucleolus and PML bodies, are also disrupted in cancer, with
the specific aberration detected dependent on the type of cancer
(Zink et al., 2004b).
While loss of genomic integrity, such as mutations,
amplifications, deletions and translocations, are hallmarks
of cancer and cancer progression (Mitelman et al., 2007;
Hanahan and Weinberg, 2011), an additional feature of the
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genome, the spatial positioning of individual genetic loci within
the interphase nucleus, may also have the potential to become a
prominent cancer biomarker.
NON-RANDOM SPATIAL ORGANIZATION
OF THE GENOME IN INTERPHASE
NUCLEI
The potential of the spatial organization of the genome to be used
as a biomarker for cancer diagnosis has been suggested by the
fact that specific genes reproducibly occupy alternative nucelar
positions within cancerous tissues compared to normal, yet are
positioned in very similar patterns between individuals in non-
diseased cells (Meaburn et al., 2009; Leshner et al., 2016; Meaburn
K. et al., 2016; Meaburn K. J. et al., 2016). Before discussing
the spatial reorganization of the genome in disease states, this
review will first focus on what is known about how the genome is
spatially organized within interphase nuclei and its role in correct
nuclear function.
The genome is highly spatially organized within the nucleus,
with, for the most part, each gene and chromosome occupying
preferred nuclear positions (Cremer and Cremer, 2001; Ferrai
et al., 2010; Dekker and Misteli, 2015; Meaburn K. et al., 2016).
Although the spatial organization of the genome is non-random
it does not mean that each allele in each cell within a population
has an identical positioning pattern. In fact, spatial genome
organization is probabilistic in nature with considerable cell-to-
cell variability, and while in the majority of cells a certain position
(e.g., internal, proximal to a nuclear speckle, etc.) will be favored,
within the population of cells a specific genomic region can be
found in any position within the cell (Parada et al., 2003; Bolzer
et al., 2005; Goetze et al., 2007; Berger et al., 2008; Tjong et al.,
2012; Dekker and Misteli, 2015; Kind et al., 2015). Moreover,
the two alleles within the same cell can adopt different positions
(Figures 1E–G), for example the clustering of chromosomes 12-
14-15 in mouse spleenocytes most often only involves 1 copy of
each chromosome per cell, with the second copy of each of these
chromosomes not clustering together (Parada et al., 2002).
The spatial positioning of genomic loci can be characterized
in several ways, the most common being radial positioning and
relative positioning (Figure 1). Radial positioning describes the
position of a locus along a central axis between the nuclear
periphery and the center of a nucleus (Figure 1C). For instance,
in many cell types human chromosome 18 preferentially locates
to the nuclear periphery, and, conversely, chromosome 19 is
positioned centrally (Croft et al., 1999; Boyle et al., 2001; Cremer
et al., 2003). On the other hand, relative positioning measures
the position of a gene or chromosome relative to another
nuclear landmark, such as to another gene or chromosome,
association with the NE or with a nuclear body, including a
transcription factory or a splicing speckle, or the position of a
gene with respect to the rest of the chromosome it is located
on (Figures 1D–G). Relative positioning can measure either
the frequency of close spatial proximity (either on per cell
or per allele basis) or the distance between the two objects.
As an example of relative positioning, in human intermediate
erythroblasts cells the α-globin gene locus frequently loops out
of its chromosome territory (Figure 1G), and is often in close
spatial proximity to the β-globin gene at splicing factor-enriched
nuclear speckles (Figure 1F) (Brown et al., 2006). Traditionally
radial and proximal positioning is measured after FISH. More
recently, biochemical methods have been developed to map the
proximity of a locus to either other genomic regions (a range
of chromatin conformation capture techniques, e.g., 3C, 4C, 5C,
GCC, HiC) or to nuclear structures (e.g., DamID, ChIA-PET)
(Rodley et al., 2009; van Steensel and Dekker, 2010; Bickmore and
van Steensel, 2013; Dekker and Misteli, 2015). These traditional
and new methods are highly complementary, and it is their
combined use that will drive forward our understanding of
genome organization. Unlike FISH, the biochemical methods are
population-based and the heterogeneity inherent in positioning,
either between individual cells or between the two alleles
of a gene within a single cell, is not captured. Conversely,
as opposed to many of the biochemical methods, FISH is
relatively low-throughput and candidate genes are required for
analysis. Thus, there exist multiple complementary methods for
examining nuclear organization. It should be noted that due to
current cost and complexity, sequencing-based methodologies
may less suitable at present for clinical use in countries with
developing economies. DNA FISH-based microscopic methods
are a potentially universal and flexible technology with relatively





The exact molecular mechanisms that regulate the spatial
organization of the genome are currently not well elucidated.
Moreover, it is not clear if the spatial organization of the genome
is important to regulate proper nuclear function or if it is
simply a byproduct of nuclear processes. Part of the difficulty
in resolving this question is that it is virtually impossible to
completely separate the various nuclear functions from each
other and, therefore, determine cause and effect. It is also likely
that different genes are regulated by different mechanisms; for
every rule suggested to govern spatial genome organization there
are multiple examples of exceptions. As such, there are multiple
layers of nuclear function that ultimately may influence gene
positioning in normal and diseased cells. There are several lines
of evidence that suggest functional importance to spatial genome
organization. The first hint comes from the fact that gene-rich
regions of the genome are spatially separated from gene-poor
regions (Boyle et al., 2001; Boutanaev et al., 2005; Clemson et al.,
2006; Shopland et al., 2006; Simonis et al., 2006; Lieberman-
Aiden et al., 2009; Boyle et al., 2011; Pichugina et al., 2016).
For instance, gene-rich chromosomes are generally internally
located whereas gene-poor chromosomes are enriched at the
nuclear periphery (Boyle et al., 2001) and within individual
chromosomes gene-poor and gene-rich chromatin are spatially
separate, even at the Mb scale (Boutanaev et al., 2005; Shopland
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et al., 2006; Lieberman-Aiden et al., 2009). This suggests that the
spatial organization of the genome is functionally important for
gene expression, or is at least dictated by gene expression. This
hypothesis is supported by the observation of spatial clustering
of some co-regulated genes, e.g., tRNA genes (Thompson et al.,
2003), KLF1-regulated genes (Schoenfelder et al., 2010), STAT-
regulated genes (Hakim et al., 2013) or olfactory receptor
genes (Clowney et al., 2012). Further, genomic regions that
are gene-poor and/or contain mostly inactive genes tend to
cluster together, for example at the nuclear lamina, around the
edge of the nucleolus or with peri-centromeric heterochromatin
(Pickersgill et al., 2006; Guelen et al., 2008; Nemeth et al., 2010;
Peric-Hupkes et al., 2010; van Koningsbruggen et al., 2010;
Kind et al., 2013; Wijchers et al., 2015). Moreover, the spatial
organization of the genome is different in cells with differing
gene expression profiles, for example the genome reorganizes
during differentiation and is different between different cell-
and tissue-types (Kosak et al., 2002; Parada et al., 2004; Solovei
et al., 2009; Peric-Hupkes et al., 2010; Foster et al., 2012; Hakim
et al., 2013; Rao et al., 2014; Meaburn K. J. et al., 2016).
While specific loci often change nuclear positions, there is not
a global spatial rearrangement of the genome between cell types.
Positioning patterns are remarkably conserved between cell types
and stages of differentiation, with only specific genomic regions
in alternative positions. For instance, in human fibroblasts and
lymphocytes most chromosomes are in similar radial positions
and only the position of chromosomes 8, 20, and 21 differ
(Boyle et al., 2001; Meaburn et al., 2008). Similarly, of the
genomic regions that associated with the nuclear lamina in mouse
embryonic stem cells and astrocytes, approximately 20% are
lamina-associated in only one of the two cell types (Peric-Hupkes
et al., 2010).
Most saliently, genes can relocate to different nuclear
locations with changes in their transcriptional output (Fraser and
Bickmore, 2007; Ferrai et al., 2010). For example, active Gfap
and Il4 alleles are generally more internally located than their
silent counterparts (Takizawa et al., 2008a) and CFTR, Mash1 and
IgH display lower association with the nuclear periphery upon
activation (Kosak et al., 2002; Zink et al., 2004a; Williams et al.,
2006). Conversely, genes, such as INO1, HXK1 and GAL1 move
to the NPC, at the periphery of the nucleus, upon activation
(Brickner and Walter, 2004; Taddei et al., 2006; Brickner et al.,
2007; Berger et al., 2008) and the “gene territories” occupied
by loci such as GAL1 increase when activated (Berger et al.,
2008). It is not only changes in radial position that are detected
to correlate with gene expression, for example, some highly
expressed gene-rich regions of the genome, including the major
histocompatibility complex, epidermal differentiation complex and
HoxB loci loop out of the bulk of their chromosome territory
when active (Volpi et al., 2000; Williams et al., 2002; Chambeyron
and Bickmore, 2004) and changes to the cell-cycle phase specific
clustering of genes sets in yeast correlated well with changes
in gene expression, particularly for genes that down regulate
during the transition of cell cycle phase (Grand et al., 2014). Not
all changes in nuclear location coincide with the exact time of
changes in expression. Some loci reposition before changes in
gene expression, adopting poised positions in the days leading up
to developmentally regulated activation of expression (Ragoczy
et al., 2003; Chambeyron and Bickmore, 2004; Peric-Hupkes
et al., 2010), suggesting, at least for some regions, changes in
nuclear positions are not simply a consequence of the activation
of gene expression. On the other hand, some genes move
only after changes in expression, for example, during erythroid
differentiation the mouse β-globin gene is activated prior to
relocation away from the nuclear periphery (Ragoczy et al., 2006).
In this case the movement of the locus might help modify the
magnitude of transcription since expression is further increased
with the repositioning (Ragoczy et al., 2006). It is not only upon
activation genes alter nuclear location. Relocation to blocks of
heterochromatin is associated with gene repression for some
genes (Brown et al., 1997, 1999; Francastel et al., 1999; Wijchers
et al., 2015); however, this is not a general rule as other silenced
gene loci do not associate with blocks of heterochromatin (Moen
et al., 2004; Takizawa et al., 2008a).
LACK OF CORRELATIONS BETWEEN
SPATIAL GENOME ORGANIZATION AND
TRANSCRIPTION
In addition to the discrepancy amongst genes on the timing of
spatial repositioning in relation to altered transcription, there are
a large number of studies demonstrating that for many genes
changes in nuclear position and gene expression are uncoupled
(Scheuermann et al., 2004; Williams et al., 2006; Kumaran and
Spector, 2008; Meaburn and Misteli, 2008; Takizawa et al., 2008b;
Morey et al., 2009; Harewood et al., 2010; Hakim et al., 2011;
Shachar et al., 2015). For instance, when a breast epithelial cell
line, MCF10A, was grown under four different growth conditions
there was no correlation between change in gene expression
and change radial positioning pattern for any of the eleven
genes analyzed (Meaburn and Misteli, 2008). There could be
several reasons to explain this. Firstly, radial positioning is not
an ideal measure to assess function (Takizawa et al., 2008b).
With the exception of the NE, all radial locations within the
nucleus are approximately equal with respect to function and
gene expression. Transcription factories and active genes are
equally distributed throughout the nucleus (Wansink et al.,
1993; Takizawa et al., 2008a; Paz et al., 2015). Thus, changes in
radial position do not necessary represent biologically relevant
changes, as they do not correlate with moving a locus into a
more or less transcriptionally active environment. Moreover,
radial positioning can miss biologically relevant changes to
positioning if it does not shift the locus to a different radial zone.
Proximity to and association with nuclear bodies is likely to be
far more important for gene expression and RNA processing
than radial positioning. Indeed, for many genes changes in gene
expression accompany changes in association with nuclear sub-
compartments, including the lamina, nucleolus, transcription
factories, heterochromatin, polycomb bodies, NPCs, Cajal bodies
and nuclear speckles (Ahmed et al., 2010; Ferrai et al., 2010;
Bickmore and van Steensel, 2013; Khanna et al., 2014; Dekker
and Misteli, 2015; Wang et al., 2016). Furthermore, transient
co-localization of X chromosomes during the establishment
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of X inactivation and co-localization of imprinted genes with
imprinting control region loci suggest a critical role for spatial
genome organization in establishing and maintaining mono-
allelic expression in these regions (Fraser and Bickmore, 2007;
MacDonald et al., 2016). However, radial positioning vs. relative
positioning cannot be the full story in explaining the differences
between the studies because some genes spatially reposition in
the absence of a change in expression. For example, Mash1
relocates to a more internal nuclear position upon activation
during neuronal differentiation, however, the repositioning is
not specific to Mash1 and several chromosomally neighboring
genes also reposition despite remaining transcriptionally silent
(Williams et al., 2006). This is not limited to transcriptionally
silent genes; active genes can also change nuclear positions
without modulating transcription. As an example, all four genes
(AKT1, BCL2, ERBB2 and VEGF) identified to change radial
position after in vitro induction of early breast cancer were
expressed at similar levels in the normal as compared to tumor
cells (Meaburn and Misteli, 2008).
Why might these differences in nuclear positioning exist
between different genes? It could be that some genes are more
sensitive to their nuclear position for expression than others,
and the genes that require specific positioning patterns for their
correct expression drive the relocation of neighboring regions by
“pulling” them along. Consistent with this, when loci are forced
into a different nuclear environment, either by being artificially
tethered or due to a chromosomal translocation, the expression
of some but not all genes is affected (Finlan et al., 2008; Kumaran
and Spector, 2008; Reddy et al., 2008; Harewood et al., 2010;
Wijchers et al., 2015). Additionally, the type of expression change
may be an important factor. Most of the genes that have been
identified to alter nuclear location in parallel with changes in gene
expression are genes that are being activated or silenced during
development and differentiation, i.e., are genes associated with
a more or less permanent change in expression, and although
these expression changes occur in a coordinated manner, it
does not need to be rapid. Thus, it could be that a specific
nuclear environment is required for this activation/repression,
and time can be taken for a locus to be relocated to this
environment, but once a gene is permanently induced or silenced
the environment can change without affecting the expression of
that region. In support, transient homologous pairing of Oct4
alleles occurs during mouse ESC differentiation only as Oct4
becomes permanently repressed (Hogan et al., 2015). It is also
likely that ongoing transcription is not required to maintain
spatial positioning patterns, since long-range DNA interactions
of active β-globin and Rad23a genes are maintained after the
inhibition of RNA polymerase II transcription (Palstra et al.,
2008). Precise spatial positioning, especially radial positioning,
may not have a significant role for all genes beyond switching
on/off. For genes that turn on and off rapidly in response to
changing environmental signals, for example upon stimulation
by a hormone or stress signals, rapid induction may be enhanced
by proximal spatial positioning of sets of co-regulated genes
prior to the stimulation, i.e., in a permanently poised position.
In keeping with this, glucocorticoid receptor responsive genes
cluster in the absence of glucocorticoid, and (re)stimulation
with glucocorticoid does not significantly change positioning
patterns (Hakim et al., 2011). Direct evidence for the concept
of a more rapid activation of expression for genes already in the
correct nuclear environment comes from yeast studies. The NPC
associates with active regions of the genome, with specific genes
recruited to the NPC upon activation (Egecioglu and Brickner,
2011; Liang and Hetzer, 2011). Even after the stimulation has
been removed and the expression from these genes has been
repressed several genes, including HXK1, GAL1 and INO1,
remain at the nuclear periphery and these peripheral loci are
activated more quickly upon future re-stimulation (Brickner
et al., 2007; Tan-Wong et al., 2009).
ADDITIONAL PLAYERS AND FUNCTIONS
Additionally, remodeling of chromatin is intimately linked to
gene expression. Thus, it is possible that chromatin remodelers
and the resulting alterations to histones and chromatin
compaction are an important part of the molecular machinery
that reorganizes the genome, rather than gene transcription
itself. Emerging evidence suggests this may well be the case.
Decondensation of chromatin in the absence of altered gene
expression, even for silent genes, is sufficient for a locus to
spatially reposition (Chambeyron and Bickmore, 2004; Therizols
et al., 2014). Similarly, modifications to histones are important
for anchoring loci to the nuclear periphery, independently of a
role in gene repression these modifications are associated with
(Harr et al., 2016). For example, histone acetyltransferase SAGA
(Dultz et al., 2016), histone deacetylases (Zullo et al., 2012;
Demmerle et al., 2013; Dultz et al., 2016) and histone H3K9 di-
and tri-methylation by histone methyltransferase (Towbin et al.,
2012; Bian et al., 2013; Kind et al., 2013; Harr et al., 2015) are
required to localize at least some genes to the nuclear periphery.
It is most likely that chromatin remodelers work in tandem
and that it is specific combinations of histone marks that are
required to target a genomic region to the nuclear periphery
(Harr et al., 2016). It is also likely that chromatin remodelers
play a role in targeting genes within the nucleoplasm, away from
the NE, since chromatin remodelers EZH2 and SUV39H1 have
been demonstrated to be critical for local chromatin clustering
into sub-domains (Wijchers et al., 2016) and knocking down a
range of chromatin remodelers and histone modifiers affected
the position of several non-NE associated genes (Shachar et al.,
2015).
In addition to gene expression and chromatin state, many
other nuclear factors have been linked to a role in correct spatial
organization of the genome, these include actin, myosin (Chuang
et al., 2006; Dundr et al., 2007; Mehta et al., 2010), NE proteins,
include A-type lamins (Meaburn et al., 2007; Mewborn et al.,
2010; Mehta et al., 2011; Kubben et al., 2012; Solovei et al., 2013;
Harr et al., 2015), B-type lamins (Malhas et al., 2007; Ranade
et al., 2016), lamin B receptor (Clowney et al., 2012; Solovei
et al., 2013), emerin (Demmerle et al., 2013) and several other
NE transmembrane proteins (Zuleger et al., 2013), NPC proteins
(Ahmed et al., 2010; Dultz et al., 2016) and non-coding RNAs
(Hacisuleyman et al., 2014).
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Interestingly, different genes can be targeted to the same
nuclear compartment via different protein complexes and
pathways, and the use of the different mechanisms may add
an additional layer of control over the speed of inducing
or enhancing gene expression (Randise-Hinchliff et al., 2016).
Moreover, different genes require different proteins complexes
for their correct nuclear location. SiRNA screening of 669 nuclear
proteins, combined with mapping the radial position of 3–4 genes
by FISH, identified 50 proteins with roles in spatially organizing
the genome. However, of these proteins, only knocking down
one, CACNG1, repositioned all four genes studied. Moreover, half
of the hits affected the position of only a single gene (Shachar
et al., 2015).
At some level underlying DNA sequence must play a role
in the spatial positioning of the genome. Transcription factors
bind to specific sequences in the genome, thereby, activating a
specific set of genes, and genes regulated by specific transcription
factors can spatially cluster (Schoenfelder et al., 2010; Hakim
et al., 2011; Hakim et al., 2013). Some specific DNA sequences
have been demonstrated to have a direct role in targeting genes to
specific locations within the nucleus. In Saccharomyces cerevisiae,
two short gene recruitment sequences, within gene promotors,
are required to target inducible genes to the NPC, allowing an
enhanced transcriptional output (Ahmed et al., 2010). It has
recently been proposed that the association between repetitive
sequences, in particular homotypic associations between short
interspersed retrotransposable elements (SINEs), which are
enriched in gene-rich regions of the genome, or long interspersed
retrotransposable elements (LINEs), which are enriched in gene-
poor regions, may be a key underling factor responsible for the
spatial separation of gene-rich and gene-poor regions of the
genome (Cournac et al., 2016; Solovei et al., 2016). However,
spatial positioning patterns cannot be an intrinsic feature of a
piece of DNA, since, as discussed above, genes and chromosomes
can alter position without changes in DNA sequence, e.g.,
between cell types or upon activation. Additionally, some human
chromosomes, including chromosome X, adopt different nuclear
positions when they are in a mouse nucleus compared to when
they are within their endogenous human cell (Meaburn et al.,
2008). It is also unlikely all repeat sequences direct spatial
organization, as pericentromeric satellite repeats migrate to
existing heterochromatin compartments during differentiation
rather than drive the aggregation of heterochromatin (Wijchers
et al., 2015).
Replication has also been linked to the spatial organization of
the genome. Genomic regions alter their nuclear location as they
change replication timing during development and disruptions to
replication can affect the radial position of some genes (Hiratani
et al., 2008; Shachar et al., 2015). Similarly, mitosis and NE
reformation in early G1 are important for some loci to establish
nuclear location, especially for gene-poor and inactive regions
when associating with the NE (Bridger et al., 2000; Kumaran and
Spector, 2008; Kind et al., 2013) or during muscle differentiation
(Neems et al., 2016). However, once more, these cannot be
general mechanisms for all genes. Firstly, several genes and
chromosomes reposition as cells exit the cell cycle and become
quiescent or senescent, which clearly occurs in the absence of
replication, mitosis and NE reformation (Bridger et al., 2000;
Solovei et al., 2004; Meaburn et al., 2007; Meaburn and Misteli,
2008). Secondly, an alternative mechanism must be required for
genes that move rapidly after stimulation. For example, relocation
to the NPC occurs within 15–60 min of activation in 60% of
nuclei (Randise-Hinchliff et al., 2016). This timing is too fast for
replication, mitosis or NE reformation to play a major role.
The spatial organization of the genome may also have a role in
DNA repair, since whole chromosomes can reposition after DNA
damage (Mehta et al., 2013; Ioannou et al., 2015), however, given
that in mammalian cells broken DNA ends do not significantly
move (Kruhlak et al., 2006; Soutoglou et al., 2007; Roukos et al.,
2013), the function of this repositioning is not clear. What is clear,
however, is the role the spatial organization plays in the partner
choice when oncogenic chromosomal translocations form, after
the DNA breaks have occurred. Translocations preferentially
form between loci that are in close spatial proximity prior to
damage (Lukasova et al., 1997; Neves et al., 1999; Roix et al.,
2003; Lin et al., 2009; Mani et al., 2009; Mathas et al., 2009;
Chiarle et al., 2011; Klein et al., 2011; Hakim et al., 2012; Roukos
et al., 2013). In a similar vein, the spatial organization of the
genome also helps dictate the integration sites of HIV-1 virus
DNA into the human genome after infection. HIV-1 integrates
preferentially into highly transcribing genes that associated with
the NPC (Lelek et al., 2015; Marini et al., 2015).
Most studies on the spatial organization of the genome focus
on its role for the correct function of the genome. However, there
is evidence to suggest the spatial organization of the genome may
have additional structural roles that aid cellular function in a
non-genetic manner (Bustin and Misteli, 2016). For example, the
clustering of condensed chromatin to the nuclear periphery helps
the nucleus withstand mechanical forces, while the redistribution
of heterochromatin to the center of the nucleus in the rod
cells of nocturnal mammals aids night vision by optimizing the
diffraction of light though the retina (Solovei et al., 2009; Bustin
and Misteli, 2016).
While trends are emerging as to how and why the genome
is spatially organized, no “one size fits all model” has yet to
clearly present itself. This is not surprising given the complexity
of the nucleus. Most likely it will be a combination of molecular
strategies working in concert, and differing depending on the
gene and the cellular context, that optimizes correct nuclear
function and organization. Until recently, due to practical
constraints, loci could only realistically be studied in virtual
isolation. With the rapidly reducing cost of sequencing and
the advent of multiple biochemical methods to analyze genome
organization on a larger scale, the tools are now in place to
study the spatial organization of chromatin on a genome-wide
scale. It will be important to compare these positioning maps
to gene expression data, epigenetic maps, proteome data, non-
coding RNA, replication timings etc., in combination. Moreover,
it will be important to not only ask what is changing at the
level of an individual locus, it will be vital to consider the
chromosomal neighborhood at large. It will be critical to study
candidate regions, identified by population-based biochemical
methods, in greater detail using single cell FISH analysis. This
will answer questions the biochemical methods can not, such
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as, in how many cells is a given positioning patterns found?
Do both alleles of a gene behave in the same manner? Are
positioning patterns found in the population mutually exclusive
at the single cell level? From here, loci or nuclear factors can
then be manipulated to determine the true functional relevance,
beyond correlation.
SPATIAL REORGANIZATION OF THE
GENOME IN NON-MALIGNANT DISEASE
Even though many mechanistic and functional aspects of the
spatial organization of the genome have yet to be resolved,
these data do indicate that discrete and quantifiable changes
to spatial positioning patterns exist between cells which, if
they occur specifically in disease states could be exploited as
biomarkers. In a wide variety of diseases, including cancer,
individual genes, genomic regions and/or whole chromosomes
are known to reposition (Figure 2) (Ferrai et al., 2010; Bridger
et al., 2014; Meaburn K. et al., 2016). This phenomenon
was first identified in the 1980s in brain tissues of epilepsy
patients (Borden and Manuelidis, 1988). The centromere of
chromosome X reproducibly redistributed away from the NE
or edge of nucleoli in neurons from the epileptic seizure
focus as compared to normal neurons from unaffected areas
of the brain from the same individuals (Figure 2) (Borden
and Manuelidis, 1988). This repositioning is not common to
other heterochromatin regions, as neither the pericentromeric
heterochromatin regions on chromosomes 1 (1q12) and 9 (9q12)
nor the large heterochromatin block mapping to Yq12 reposition
(Figure 2) (Borden and Manuelidis, 1988). Generally speaking,
different loci have been positioned in different diseases, with very
few loci studied in more than one aﬄiction, making it unclear
how general the disease-related repositioning of a given locus is.
At least some repositioning events are different between different
diseases, however. While 1q12 is not repositioned in epilepsy,
in the lymphocytes from patients with endometriosis 1q12 is
more peripherally located, compared to control individuals,
(Mikelsaar et al., 2014) and more internally located in ICF
patient lymphocytes (Jefferson et al., 2010; Dupont et al., 2012).
Additional genomic regions were also found to reposition
in ICF, including a reduced association of chromosome 16’s
pericentromeric heterochromatin region with the NE, and an
increased incidence of human pseudoautosomal region 2 genes
looping out of their chromosome territories (chromosome Y and
the inactive X) (Matarazzo et al., 2007; Jefferson et al., 2010).
Similarly to epilepsy, loci-specific repositioning was observed
in ICF, with other regions on chromosome 1 (BTG2, CNN3,
ID3, and RGS1) and the pericentromeric heterochromatin of
chromosome 9 not repositioning in ICF (Jefferson et al., 2010;
Dupont et al., 2012). Pericentromeric loci are not the only repeat
sequences to be spatially affected in disease. Aberrant telomere
clustering has been identified in several diseases, including
cancer and Alzheimer’s, often due to telomere dysfunction, and
the degree of clustering can reflect the aggressiveness of the
disease (Chuang et al., 2004; Gadji et al., 2010; Mathur et al.,
2014).
Loci-specific repositioning also occurs in laminopathies
(Figure 2) (Meaburn et al., 2007; Taimen et al., 2009; Mewborn
et al., 2010; Mattout et al., 2011; Mehta et al., 2011; McCord
et al., 2013). Laminopathies are a wide ranging group of rare
diseases characterized by mutations in lamin A/C, and includes
Emery-Dreifuss muscular dystrophy and the premature aging
disease HGPS (Dittmer and Misteli, 2011). The organization
of chromosomes in proliferating laminopathy fibroblasts cells
mimics that of normal quiescent cells, with chromosomes
13 and 18 shifted to a more internal position, chromosome
10 repositioning towards the nuclear periphery, however,
chromosomes 4 and X remaining at the nuclear periphery
(Figure 2) (Meaburn et al., 2007; Mewborn et al., 2010; Mehta
et al., 2011). Moreover, there is evidence to suggest that the
spatial reorganization of the genome in laminopathies is not
limited to the repositioning of a few specific chromosomes,
and may evolve as the cells increase in passage. Compared
to proliferating normal fibroblasts, a dramatic genome-wide
reduction in the spatial separation of active and inactive
chromatin was observed in senescent HGPS fibroblasts (McCord
et al., 2013). Some of these differences in interaction frequencies
were senescence- rather than disease-related, since they were
mostly not detected in proliferating HGPS cultures (McCord
et al., 2013) yet were detected in normal senescent fibroblasts
(Chandra et al., 2015). Yet, differences between normal senescent
and senescent HGPS cells were detected (Chandra et al., 2015).
It remains unclear how disease related these differences are,
as it could be more a reflection of the type of senescence
being compared. The HGPS cells used had reached (early)
replicative senescence by continued culture (McCord et al.,
2013), whereas senescence was induced in the normal cells by
oncogene activation, which, unlike replicative senescence, forms
senescence-associated heterochromatin foci (Chandra et al.,
2015). The redistribution of the genome in progeria may well be
progressive, as is pointed to by the findings that the abnormal
clustering of centromeres associated with the LMNA E145K
mutation only occurs in nuclei with aberrant shapes, and the
prevalence increases with increased time in culture (Taimen et al.,
2009).
The specific functional relevance of the spatial repositioning
of the genome to the various disease phenotypes present in
the different laminopathies is unclear, and appears to result
more generally from the presence of aberrant A-type lamin
rather than the specific disease per se. Generally, the spatial
reorganization of the genome is very similar between different
laminopathy patients, regardless of the disease or mutation
present (Meaburn et al., 2007; Mewborn et al., 2010), the
exception being that chromosome 13 is more peripheral in
patients with 1303 or D596N LMNA mutations (Mewborn
et al., 2010) and the spatial organization of the genome
in asymptomatic laminopathy carriers is very similar to the
laminopathy patients (Meaburn et al., 2007). The release
of chromosome 13 and 18 from the nuclear periphery in
laminopathy fibroblasts may be linked to an altered ability of
the mutant A-type lamin proteins to bind specific chromatin
regions (Meaburn K. et al., 2016) and/or changes in chromatin
status, since there is a reduction of heterochromatin-specific
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FIGURE 2 | Loci-specific reorganization of the genome in disease. Certain loci adopt alternative nuclear positions in disease (tick) compared to normal cells,
whilst the positions of other loci are conserved in disease (cross). Moreover, the repositioning of some loci is disease specific, and although a gene repositions in one
disease, it may not in another disease. Blue, nucleus; NE, nuclear envelope; Cent., Centromere.
markers, including HP1α and histone H3K9 methylation, in
HGPS fibroblasts (Scaffidi and Misteli, 2005), or it may be
due to an uncoupling of cell-cycle regulation and spatial
positioning patterns (Meaburn et al., 2007). Interesting, while few
differences in positioning patterns have been detected between
fibroblast cell lines of different laminopathies, the laminopathy-
related spatial positioning patterns are tissue-specific, suggesting
they may contribute to the disease phenotype. Chromosomal
positioning abnormalities have not been detected in laminopathy
patient lymphoblasts, a cell-type that does not require A-type
lamins (Boyle et al., 2001; Meaburn et al., 2005). Further, in
a Caenorhabditis elegans model of Emery-Dreifuss muscular
dystrophy, a muscle-specific promotor was retained at the NE in
the muscles of diseased animals, however, the release from the NE
of a gut-specific promotor was not affected in gut tissue (Mattout
et al., 2011).
In addition to the repositioning of gene poor regions of
the genome in disease, several genes have been identified to
occupy disease-specific positions. In benign prostate hyperplasia
tissues MMP2 shifts to a more peripheral position than normal
prostate tissue (Figure 2) (Leshner et al., 2016). Benign prostate
hyperplasia is not associated with a general reorganization of the
genome, since the positions of MMP9 and FLI1 are unaffected
(Figure 2) (Leshner et al., 2016). In lymphocytes from Down
syndrome patients, two (or three) copies of chromosome 21
clusters together more frequently than in diploid control cells
(Figure 2) (Paz et al., 2013, 2015). Moreover, SOD1, which
is located on chromosome 21, is more peripherally located
in Down syndrome (Paz et al., 2015). This altered position
is not simply a consequence of the presence of an additional
chromosome 21, however, as the radial position of DYRK1A,
which also maps to chromosome 21, is unaffected (Paz et al.,
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2015). It is not only chronic diseases that are associated with a
spatial reorganization of the genome. Short-term repositioning
of some, but not all, genes or chromosomes occurs after viral or
parasitic infection (Li et al., 2010; Knight et al., 2011; Arican-
Goktas et al., 2014). Chromosome 17, but not 18, relocates to a
more peripheral position in human lymphocytes within 24 h of
Epstein-Barr virus infection (Li et al., 2010). Similarly, dynamic
radial repositioning of actin, ferritin and hsp70, occurs in both
cultured snail cells and in intact live snails within hours of active
parasitic infection, with the repositioning correlating to changes
in gene expression (Knight et al., 2011; Arican-Goktas et al.,
2014).
In most cases the link between gene repositioning in disease
and the disease phenotype has not clear. In a few cases a
direct link between altered positioning patterns and disease
relevant gene expression has been demonstrated. The spatial
clustering of FTO and IRX3 is implicated in obesity, by altering
the expression of IRX3 expression and consequently mis-
regulating body mass (Smemo et al., 2014). Local disruptions
to hierarchical genome organization can also be important
for disease progression. High-resolution mapping of the 3D
genome has revealed that beyond a spatial separation of gene-
rich and gene-poor chromatin, chromosomes further fold into
a succession of ten to hundreds of kb long self-associating
globular domains, known as TADs (Dixon et al., 2012; Nora
et al., 2012; Sexton et al., 2012). Individual TADs are stably
conserved between species and cell types and are separated by
sharp boundaries that are enriched in histone marks associated
with active genes, SINEs, binding sites for the chromatin-
binding protein CTCF and housekeeping genes (Dixon et al.,
2012). TAD boundaries are believed to be important for gene
regulation, by acting as insulators, inhibiting the expansion of
either heterochromatin or active chromatin into a neighboring
TADs and by increasing the frequency of specific regulatory
interactions by confining certain promoters and enhances into
a single TAD (Dixon et al., 2012; Sexton et al., 2012; Narendra
et al., 2015). Consentient with this, genes within TAD domains
are co-expressed during differentiation and disruption of TAD
boundaries results in a partial or complete fusion of neighboring
TADs leading to altered gene expression and in some cases,
disease phenotypes (Nora et al., 2012; Lupianez et al., 2015;
Narendra et al., 2015; Hnisz et al., 2016). Disruption to the
TAD boundary near the EPHA4 locus by deletion, duplication
or inversion of DNA sequences at the boundary results in limb
deformation syndromes (Lupianez et al., 2015). In normal limb
development EPHA4 is active but genes in neighboring TADs
are silent. The loss of the TAD boundary allows enhancer-
promoter interactions between regulatory sequences normally
separated into different TADs, and consequently results in the
spuriously activation of the neighboring genes in the mis-
fused TAD (Lupianez et al., 2015). Similarly, cancer-associated
micro-deletions or mutations at TAD boundaries can activate
oncogenes, and may represent a common mechanism of gene
mis-regulation in multiple cancers (Hnisz et al., 2016). The study
of TADs is still in its infancy, and most likely disruption to TAD
boundaries will be detected as functionally important in many
other diseases.
SPATIAL GENOME ORGANIZATION IN
CANCER
Given the urgent need for additional diagnostic and prognostic
tests for cancer, reproducible differences in the spatial positioning
patterns of the genome detected between normal/benign tissues
and cancer, or between different cancer subtypes could be
invaluable clinically. As with non-malignant disease, some genes
and chromosomes occupy distinct nuclear positions in cancerous
cells compared to their normal or benign counterparts (Figure 2)
(Cremer et al., 2003; Murata et al., 2007; Meaburn and Misteli,
2008; Meaburn et al., 2009; Wiech et al., 2009; Zeitz et al., 2013;
Leshner et al., 2016; Meaburn K. J. et al., 2016). For example,
in breast cancer cell lines there is a significant change to the set
of genes that are close spatial neighbors of IGFBP3 (Zeitz et al.,
2013). Moreover, ten genes (FLI1, HES5, MMP9, HSP90AA1,
TGFB3, MYC, ERBB2, FOSL2, CSF1R and AKT1) have been
identified to reproducibly radially reposition in epithelial cells
of breast cancer tissues (Meaburn et al., 2009, Meaburn K. J.
et al., 2016) and FLI1, MMP9 and MMP2 occupy alternative
radial locations in prostate cancer (Leshner et al., 2016). Also in
line with non-malignant diseases, and despite the high level of
genomic instability associated with many cancers, which could
conceivably be expected to result in a large-scale disruption
to the spatial organization of the genome, the repositioning is
loci-specific, with a general conservation of spatial positioning
patterns in cancer, with the majority of genes and chromosomes
not altering nuclear position (Kozubek et al., 2002; Parada et al.,
2002; Cremer et al., 2003; Meaburn and Misteli, 2008; Meaburn
et al., 2009; Timme et al., 2011; Zeitz et al., 2013; Leshner et al.,
2016; Meaburn K. J. et al., 2016). For example, 44 of 47 (94%)
genes spatially mapped in human prostate tissues do not alter
radial position in prostate cancer and the radial positions of 13
out of 23 (57%) genes are conserved in breast cancer (Meaburn
et al., 2009; Leshner et al., 2016; Meaburn K. J. et al., 2016).
Unlike laminopathies, the patterns of spatial reorganization
differ between different cancers. While the radial positions of
chromosomes 18 and 19 are affected in many cancer types,
including thyroid, colon and cervical cancer, with a tendency
for chromosome 18 to become more internally located and
chromosome 19 to shift away from the center of the nucleus
(Cremer et al., 2003; Murata et al., 2007; Wiech et al., 2009), in
some cervical cancers, chromosome 18 becomes more internally
located (Wiech et al., 2009). Moreover, of the eleven genes
so far reported with altered radial position in either breast or
prostate cancer, only MMP9 and FLI1 robustly reposition in both
types of cancer (Figure 2) (Leshner et al., 2016; Meaburn K.
J. et al., 2016). This suggests cancer-type specific repositioning,
with different sets of genes repositioning in breast and prostate
cancer. Similarly, BCL2 repositions in a BCL2-positive cervical
squamous carcinoma, but not in a BCL2-negative cervical
squamous carcinoma (Wiech et al., 2009), nor in breast (Meaburn
et al., 2009) or prostate cancer (Leshner et al., 2016). When taken
together with the findings discussed above that a genomic region
can behave differently, with respect to repositioning between
different non-cancerous diseases, it suggests that the overall
organization of the genome in disease is, mostly, specific to
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the disease and not a consequence of a more general “stress”
response. In keeping with this, of the genes that occupy distinct
radial positions in breast and/or prostate cancer, only MMP2
and ERBB2 are also commonly repositioned in non-malignant
breast or prostate disease; but even for these gene it cannot be
a general disease response as MMP2 repositions in prostate but
not breast cancer and visa versa ERBB2 does not reposition in
prostate cancer (Figure 2) (Meaburn et al., 2009; Leshner et al.,
2016; Meaburn K. J. et al., 2016). Thus, there appear to be an
exploitable minority of gene repositioning events that could be
used to distinguish cancerous tumors from normal tissue and
between different cancer types.
It is interesting to note that many of the factors implicated in
influencing gene positioning patterns, as discussed earlier in this
review, are often altered in cancer, e.g., lamins, gene expression,
proliferation status, chromatin status and histone modifications.
However, the mechanisms involved in the mis-organization of
the genome in cancer are unclear. It would seem that, for the
radially repositioned genes at least, transcription of the locus
itself is not the key to the repositioning. No correlation was
found for the repositioning of a given gene and its transcriptional
output in a model of early cancer (Meaburn and Misteli, 2008).
Moreover, cancer-associated genes, that are known to have
altered expression in cancer, often did not reposition in breast or
prostate cancer (Meaburn and Misteli, 2008; Meaburn et al., 2009;
Leshner et al., 2016). Even for the cancer-associated genes that do
reposition in cancer, it may not be altered transcription of the loci
that is driving the alternative positioning pattern. For example,
although elevated expression of MMP9 and MMP2 is a marker
of poor prognosis in prostate cancer, and linked to metastasis,
their expression is from tumor-associated stroma cells and not
from the cancerous epithelial cells, where the gene repositioning
was detected (Egeblad and Werb, 2002; Leshner et al., 2016). This
does not rule out gene expression as a factor in repositioning, and
further studies are required that measure gene expression changes
in extended chromosomal regions of the repositioned gene.
However, it does suggest that clinical diagnostic tests based on
spatial gene positioning would be independent of gene expression
and would not be a more convoluted way to get to the same result
as a gene-expression based diagnostic test, and instead would be
an independent biomarker that could be used in combination
with existing diagnostic and prognostic strategies.
An increase in proliferation is a hallmark of cancer yet spatial
positioning patterns are can also be influenced by proliferation.
Again, the spatial reorganization of the genome in cancer seems
to be independent of this, and does not seem to simply be
a reflection of a transition from quiescent normal breast or
prostate tissue to a proliferating tumor. The spatial genome
organization patterns in cancer cells do not mimic proliferating
(or quiescent) breast epithelial cells (Meaburn and Misteli, 2008).
This is not surprising, given the fact that the majority of cells
within a cancerous tumor are actually not proliferating. Ki-67
is commonly used as a marker of cellular proliferation, since it
is present in all stages of the cell cycle with the exception of
G0. Breast cancers that contain at least 30% Ki-67 positive cells
are classified as highly proliferative cancers, and the majority of
breast cancers, almost 60%, have only 10% or less of cells positive
for Ki-67 (de Azambuja et al., 2007; Jonat and Arnold, 2011). In
fact, no feature of a genomic locus has yet been identified that
enables the prediction of whether a gene will reposition or not in
cancer (Meaburn et al., 2009; Leshner et al., 2016; Meaburn K. J.
et al., 2016), again suggesting spatial positioning patterns will be
independent of other biomarkers.
CLINICAL BIOMARKER POTENTIAL
Regardless of why the genome is spatially reorganized in the
nuclei of cancer cells, the small scale studies so far performed
suggest that these differences in positioning patterns have the
potential to be exploited for diagnostic use (Meaburn et al., 2009;
Leshner et al., 2016; Meaburn K. J. et al., 2016). Distinguishing
cancer from normal tissue by spatial gene positioning patterns
could practically be integrated into clinical use because it requires
only a small tissue sample for analysis (100–1000s of cells),
meaning it will not require additional invasive procedures for the
patient. Moreover, FISH is currently already used in diagnostic
labs, thus, the infrastructure for such analysis already exists
in the clinic, at least in many developed countries. It remains
to be seen the practicality of such a diagnostic technology for
all developing economies. Importantly for clinical applications,
for most genes tested, at least in the small scale studies so far
performed, false positive rates were low since for the vast majority
of genes spatial positioning patterns are highly similar between
individuals in non-diseased tissue (Borden and Manuelidis, 1988;
Wiech et al., 2005; Murata et al., 2007; Meaburn et al., 2009;
Leshner et al., 2016; Meaburn K. J. et al., 2016) and repositioning
events did not generally occur in non-malignant breast and
prostate disease (Meaburn et al., 2009; Leshner et al., 2016;
Meaburn K. J. et al., 2016). There were a few notable exceptions,
MMP2 and ERBB2 repositions in both cancer and non-malignant
disease (Figure 2), and the radial position of a few genes, such
as CCND1 and TIMP3, were highly variable between normal
prostate tissues. This highlights that each candidate marker gene
must be rigorously tested to eliminate genes with high false
positive rates, as is standard practice for any marker brought
to the clinic. Critically, particularly when genes are used in
combination, spatial positioning patterns can detect breast or
prostate cancer with high accuracy (Meaburn et al., 2009; Leshner
et al., 2016; Meaburn K. J. et al., 2016). When genes are used
as markers singularly, between 64 and 100% of samples are
correctly identified as cancer based on radial positioning patterns.
Multiplexing genes improved the accuracy of cancer detection
for genes with lower sensitivities, reducing false negative rates
(Meaburn et al., 2009; Leshner et al., 2016; Meaburn K. J. et al.,
2016). Repositioning events are independent of variations in copy
number and even in the background of highly variable, and
in some cases large scale, genomic instability between cancer
specimens, it is possible to use gene positioning to accurately
distinguish cancers from control tissue-specimens (Meaburn and
Misteli, 2008; Meaburn et al., 2009; Leshner et al., 2016; Meaburn
K. J. et al., 2016).
Although these studies represent the largest analysis of
genome organization in cancerous tissues performed to date,
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the eleven genes identified as potential breast or prostate cancer
biomarkers were analyzed in a low number of individuals (11–
19 cancers, 6–10 normal tissues and 5 non-malignant disease
tissues), in tissues that were known to be cancerous or benign
and were performed by the same group (Meaburn et al., 2009;
Leshner et al., 2016; Meaburn K. J. et al., 2016). Moreover,
these studies were not performed on tissue biopsies. This makes
comparing the accuracies of gene-positioning based diagnostics
with current diagnostic strategies impossible currently. The
accuracy of current diagnostic tests reported are based on 100s
and 1000s of biopsy specimens, from multiple testing sites, and
will include sampling errors (e.g., no cells in the sample, the
biopsy missing the tumor and collecting only normal tissue, the
protocol failing to stain etc.). Larger scale follow-up studies are
required to assess the sensitivity and specificity of these spatial
positioning gene markers, to determine if they are strong enough
for clinical use. It will be important to compare gene-positioning
biomarkers to existing diagnostic methodologies and to establish
if using the various methods in combination, or alone, improves
diagnostic accuracy.
PROGNOSTIC POTENTIAL FOR SPATIAL
GENOME ORGANIZATION?
Additionally, the original studies were not designed to determine
if the spatial organization of the genome in cancer has
prognostic value. Yet prognostic markers are the most urgent
cancer biomarkers required to distinguish aggressive cancer
from indolent, thereby reducing overtreatment caused by over-
diagnosis. It is difficult to accurately assess the current level of
overdiagnosis, since directly measuring overdiagnosis involves
monitoring the progress of the cancer and the cause of death
of cancer patients, without treating the individuals and is also
dependent on the precise definition of “clinically relevant” cancer.
Nevertheless, for breast and prostate cancer, estimates suggest
overdiagnosis is in the range of 22–67% of cancers (Draisma et al.,
2009; Welch and Black, 2010; Bleyer and Welch, 2012; Sandhu
and Andriole, 2012; Miller et al., 2014). Using prostate cancer
mortality as an endpoint, as many as 84% of PSA screen-detected
prostate cancers may be overdiagnosed (McGregor et al., 1998).
Breast and prostate cancers are highly prevalent, with almost
1.7 million women and 1.1 million men worldwide diagnosed
with these cancers, respectively, in 2012 (Torre et al., 2015).
In the USA, where population-based screening for breast and
prostate cancer is common, over 240,000 women and more than
180,000 men per year are diagnosed, respectively (Siegel et al.,
2016). Given these numbers, even taking the low estimate of
overdiagnosis of 1 in 5 cancers additional prognostic markers
could benefit 100s of 1000s of patients every year and reduce
health care costs considerably.
Histological assessment of tissue specimens can be beneficial
in the clinical setting to reduce overtreatment. For example,
pathologists classify histological patterns within prostate cancer
tissue according to the Gleason grading system, which broadly
correlates with the differentiation status of the cancerous tissue
(Montironi et al., 2005; Epstein et al., 2016). Gleason scores,
particularly when used in combination with other clinical
factors, including PSA level and clinical tumor stage, are the
strongest markers of prostate cancer prognosis and progression
currently available (D’Amico et al., 1998; Montironi et al., 2005;
Cooperberg et al., 2009; Chang et al., 2014; Epstein et al., 2016).
Part of the strength of the Gleason scoring system is that it
takes into account intra-individual tumor heterogeneity (Van
der Kwast, 2014; Epstein et al., 2016). A low Gleason score
(Gleason score 6 or below) is highly indicative of an indolent
cancer, and often monitoring the tumor (watchful-waiting/active
surveillance) is recommend in place of treatment (Thompson
et al., 2007). However, additional markers are required as both
under- and over-treatment remain an issue (Cooperberg et al.,
2010). Additionally, histological analysis of tissues is, by its
very nature, subjective, which can lead to inter- and intra-
observer variations. Taking the example of prostate cancer
again, two pathologists will agree on the Gleason score of an
individual cancer tissue 36–81% of the time (Montironi et al.,
2005). Similarly, the same pathologist will derive an identical
Gleason score for the same tissue specimen 43–78% of the time
(Montironi et al., 2005). Most frequently, the difference in score
varies by a single Gleason grade, suggesting these small variations
would make little difference to most patients. However, for men
with Gleason score 6 or 7 cancers this could mean the difference
between receiving treatment or not. The addition of quantitative
diagnostic/prognoistic makers, to be used alongside histological
analysis, would reduce inter- and intra-observer variations, and
thus reduce overtreatment.
Given the fact that the position of a gene can vary between
cancers derived from the same organ, and between cancers from
different organs (Meaburn et al., 2009; Wiech et al., 2009; Leshner
et al., 2016; Meaburn K. J. et al., 2016), it suggests the possibility
that the spatial organization of the genome can be used to sub-
type cancers for prognostic purposes. It is “simply” a matter of
finding the right genes. Due to the selection criteria to identify
a diagnostic spatial positioning biomarker, which is required
to repositioning in the majority of prostate cancer specimens
(compared to normal), it is likely different gene loci will be
useful prognostics biomarkers than for diagnostic markers. For
example, FLI1 repositions in 100% (10/10) of breast cancers and
92.9% (13/14) of prostate cancers (Leshner et al., 2016; Meaburn
K. J. et al., 2016), rates far too high to suggest it can be used
to stratify indolent and aggressive cancers. Future screening
studies are required, using a highly defined set of indolent and
aggressive cancers. Since spatial reorganization of the genome has
been identified in multiple human diseases, it is likely that the
same principle of using spatial genome positioning patterns as a
diagnostic biomarker could be applied to any disease.
SUMMARY
The genome is highly spatially organized, and reorganizes in
disease. Accumulating evidence suggests that these repositioning
patterns can be exploited for diagnostic use. Currently, there is no
way to predict which genes will reposition in cancer. As we gain
a better understanding of how spatial positioning is regulated in
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a normal cell, it may become easier to predict regions that will
be diagnostically interesting. The reverse is also true. Comparing
positioning patterns between normal and diseased cells will
inform our understanding of spatial genome organization. While
it is exciting that proof-of-principle studies have identified spatial
positioning of the genome as a potentially sensitive and specific
biomarker of cancer, much work is yet to be done. Large-scale
follow-up studies are required to determine the feasibility and
usefulness of spatial genome organization-based diagnostic in the
clinical setting. Moreover, while additional diagnostic tests have
their use, there is urgent need for biomarkers that can distinguish
aggressive cancers from indolent ones. These markers would have
a tremendous impact on cancer patients, by guiding clinicians to
the best treatment regime for an individual and reducing both
under and over-treatment. As such, as future studies relating to
genome organization for clinical use should focus on prognostics
rather than simply diagnostics.
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